您的购物车当前为空
别名 LY-333531 Mesylate, LY-333531, LY333531, LY 333531
Ruboxistaurin is a PKC beta inhibitor. Ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways. Ruboxistaurin inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.

Ruboxistaurin is a PKC beta inhibitor. Ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways. Ruboxistaurin inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 858 | 5日内发货 | |
| 25 mg | ¥ 5,850 | 1-2周 | |
| 50 mg | ¥ 7,610 | 1-2周 | |
| 100 mg | ¥ 11,800 | 1-2周 |
Ruboxistaurin mesylate 相关产品
| 产品描述 | Ruboxistaurin is a PKC beta inhibitor. Ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways. Ruboxistaurin inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt. |
| 靶点活性 | PKCβI:4.7 nM, PKCδ:250 nM, PKCγ:300 nM, PKCα:360 nM, PKCη:52 nM, PKCε:600 nM, PKCβII:5.9 nM |
| 别名 | LY-333531 Mesylate, LY-333531, LY333531, LY 333531 |
| 分子量 | 564.65 |
| 分子式 | C29H32N4O6S |
| CAS No. | 192050-59-2 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容